{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:54:14Z","timestamp":1790171654419,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"BOF GOA UA"},{"name":"Fund for Scientific Research Flanders"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bone.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:39:04Z","timestamp":1471048744000},"page":"37-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-8530","authenticated-orcid":false,"given":"Lorenzo","family":"Glorie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D'Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1464-5491.2000.00234.x","article-title":"Correlations between insulin sensitivity and bone mineral density in non-diabetic men","volume":"17","author":"Abrahamsen","year":"2000","journal-title":"Diabet. Med."},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/sj.ijo.0801806","article-title":"Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y","volume":"25","author":"Ainslie","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.bone.2016.08.009_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1472-6823-13-35","article-title":"Beneficial association of serum ghrelin and peptide YY with bone mineral density in the Newfoundland population","volume":"13","author":"Amini","year":"2013","journal-title":"BMC Endocr. Disord."},{"issue":"9","key":"10.1016\/j.bone.2016.08.009_bb0020","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.metabol.2005.04.005","article-title":"Current knowledge in the neurophysiologic modulation of obesity","volume":"54","author":"Angelopoulos","year":"2005","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bone.2016.08.009_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2012.11.002","article-title":"Effect of glucagon-like peptide-2 exposure on bone resorption: effectiveness of high concentration versus prolonged exposure","volume":"181","author":"Askov-Hansen","year":"2013","journal-title":"Regul. Pept."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trsl.2013.07.011","article-title":"The serum level of soluble CD26\/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes","volume":"162","author":"Aso","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.bone.2016.08.009_bb0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.phrs.2015.08.023","article-title":"Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis","volume":"100","author":"Baerts","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0040","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/JOE-12-0092","article-title":"Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2","volume":"213","author":"Baldassano","year":"2012","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI0214588","article-title":"Hypothalamic Y2 receptors regulate bone formation","volume":"109","author":"Baldock","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bone.2016.08.009_bb0055","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1359\/jbmr.060705","article-title":"Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways","volume":"21","author":"Baldock","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"26","key":"10.1016\/j.bone.2016.08.009_bb0060","doi-asserted-by":"crossref","first-page":"19092","DOI":"10.1074\/jbc.M700644200","article-title":"Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis","volume":"282","author":"Baldock","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0065","doi-asserted-by":"crossref","first-page":"e8415","DOI":"10.1371\/journal.pone.0008415","article-title":"Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight","volume":"4","author":"Baldock","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.08.009_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2205","article-title":"Neuropeptide Y attenuates stress-induced bone loss through suppression of noradrenaline circuits","author":"Baldock","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1381\/096089206776944959","article-title":"Peptide YY(1-36) and peptide YY(3-36): part I. Distribution, release and actions","volume":"16","author":"Ballantyne","year":"2006","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ab.2003.08.032","article-title":"Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats","volume":"323","author":"Batchelor","year":"2003","journal-title":"Anal. Biochem."},{"issue":"21","key":"10.1016\/j.bone.2016.08.009_bb0085","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/0006-2952(79)90058-3","article-title":"Substance P: in vitro inactivation by rat brain fractions and human plasma","volume":"28","author":"Berger","year":"1979","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1534734611400256","article-title":"Review: the diabetic bone: a cellular and molecular perspective","volume":"10","author":"Blakytny","year":"2011","journal-title":"The International Journal of Lower Extremity Wounds"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0095","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.bone.2016.08.009_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0303-7207(01)00405-1","article-title":"Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects","volume":"177","author":"Bollag","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MOG.0b013e32835004c6","article-title":"Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors","volume":"28","author":"Bortvedt","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.peptides.2008.01.022","article-title":"Novel stable PACAP analogs with potent activity towards the PAC1 receptor","volume":"29","author":"Bourgault","year":"2008","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1753-0407.2011.00168.x","article-title":"Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients","volume":"4","author":"Bunck","year":"2012","journal-title":"J Diabetes"},{"issue":"7118","key":"10.1016\/j.bone.2016.08.009_bb0120","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.315.7118.1255","article-title":"Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial","volume":"315","author":"Cadogan","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1210\/jc.2009-2054","article-title":"Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men","volume":"95","author":"Carr","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0130","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00493.2012","article-title":"Emerging neuropeptide targets in inflammation: NPY and VIP","volume":"304","author":"Chandrasekharan","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0135","doi-asserted-by":"crossref","first-page":"e65505","DOI":"10.1371\/journal.pone.0065505","article-title":"Chronic central administration of Ghrelin increases bone mass through a mechanism independent of appetite regulation","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0140","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3168\/jds.2010-3205","article-title":"Characterization of glucagon-like peptide 2 pathway member expression in bovine gastrointestinal tract","volume":"93","author":"Connor","year":"2010","journal-title":"J. Dairy Sci."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00369216","article-title":"Insulin increases histomorphometric indices of bone formation in vivo","volume":"59","author":"Cornish","year":"1996","journal-title":"Calcif. Tissue Int."},{"issue":"6 Pt 1","key":"10.1016\/j.bone.2016.08.009_bb0150","first-page":"E1113","article-title":"Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo","volume":"273","author":"Cornish","year":"1997","journal-title":"Am. J. Phys."},{"issue":"4 Pt 1","key":"10.1016\/j.bone.2016.08.009_bb0155","first-page":"E694","article-title":"Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice","volume":"275","author":"Cornish","year":"1998","journal-title":"Am. J. Phys."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S8756-3282(01)00494-X","article-title":"Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development","volume":"29","author":"Cornish","year":"2001","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbrc.2004.04.020","article-title":"Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1","volume":"318","author":"Cornish","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0175","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00642.2005","article-title":"Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo","volume":"292","author":"Cornish","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.08.009_bb0180","doi-asserted-by":"crossref","first-page":"605193","DOI":"10.1155\/2011\/605193","article-title":"Ghrelin is an osteoblast mitogen and increases osteoclastic bone resorption in vitro","volume":"2011","author":"Costa","year":"2011","journal-title":"International Journal of Peptides"},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0185","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.071202","article-title":"Impact of glucose-dependent insulinotropic peptide on age-induced bone loss","volume":"23","author":"Ding","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.08.009_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bone.2014.07.030","article-title":"Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture","volume":"68C","author":"Driessen","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2016.08.009_bb0195","article-title":"Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs","author":"Driessen","year":"2015","journal-title":"Calcif. Tissue Int."},{"issue":"10","key":"10.1016\/j.bone.2016.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pds.3837","article-title":"Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugs","volume":"24","author":"Driessen","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"issue":"7032","key":"10.1016\/j.bone.2016.08.009_bb0210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","article-title":"Leptin regulation of bone resorption by the sympathetic nervous system and CART","volume":"434","author":"Elefteriou","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.bmb.a071771","article-title":"Vasoactive intestinal polypeptide: functional aspects","volume":"38","author":"Fahrenkrug","year":"1982","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.peptides.2006.09.027","article-title":"Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4","volume":"28","author":"Frerker","year":"2007","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0225","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1359\/JBMR.041237","article-title":"Ghrelin directly regulates bone formation","volume":"20","author":"Fukushima","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"2013","key":"10.1016\/j.bone.2016.08.009_bb0230","article-title":"The effect of DPP-IV inhibition on bone in a mouse model of type 2 diabetes","author":"Gallagher","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0235","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bone.2012.11.039","article-title":"Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice","volume":"53","author":"Gaudin-Audrain","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molmet.2013.06.002","article-title":"A role for PYY3-36 in GLP1-induced insulin secretion","volume":"2","author":"Gautier-Stein","year":"2013","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0245","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","article-title":"DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats","volume":"307","author":"Glorie","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.npep.2006.11.002","article-title":"Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors","volume":"41","author":"Goto","year":"2007","journal-title":"Neuropeptides"},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0255","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/clinchem\/34.12.2499","article-title":"Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients","volume":"34","author":"Gotoh","year":"1988","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1479-5876-11-271","article-title":"IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand","volume":"11","author":"Guerra-Menendez","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bone.2016.08.009_bb0265","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/bonekey.2013.171","article-title":"IGF-1 regulation of key signaling pathways in bone","volume":"2","author":"Guntur","year":"2013","journal-title":"BoneKEy Reports"},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0270","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/003655202317316006","article-title":"Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon","volume":"37","author":"Haderslev","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrendo.2011.233","article-title":"Bone, sweet bone-osteoporotic fractures in diabetes mellitus","volume":"8","author":"Hamann","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0280","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00198-007-0487-9","article-title":"Leptin and the sympathetic connection of fat to bone","volume":"19","author":"Hamrick","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bone.2003.11.020","article-title":"Leptin deficiency produces contrasting phenotypes in bones of the limb and spine","volume":"34","author":"Hamrick","year":"2004","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0290","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0196-9781(99)00176-X","article-title":"Structure, measurement, and secretion of human glucagon-like peptide-2","volume":"21","author":"Hartmann","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.bone.2016.08.009_bb0300","article-title":"Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women","author":"Hegazy","year":"2014","journal-title":"J. Bone Miner. Metab."},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0305","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bone.2003.09.009","article-title":"Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2","volume":"34","author":"Henriksen","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0315","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","article-title":"Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women","volume":"40","author":"Henriksen","year":"2007","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0320","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.npep.2009.04.005","article-title":"Rapid change of neuropeptide Y levels and gene-expression in the brain of ovariectomized mice after administration of 17beta-estradiol","volume":"43","author":"Hilke","year":"2009","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0330","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1083\/jcb.200809113","article-title":"The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity","volume":"183","author":"Hinoi","year":"2008","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dmrr.2502","article-title":"Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus","volume":"30","author":"Hirshberg","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"1\u20133","key":"10.1016\/j.bone.2016.08.009_bb0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00185-3","article-title":"Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2","volume":"93","author":"Holst","year":"2000","journal-title":"Regul. Pept."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0350","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0355","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.biocel.2010.03.020","article-title":"Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells","volume":"42","author":"Hosogane","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0360","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvr014","article-title":"Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heart","volume":"90","author":"Huber","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.bone.2016.08.009_bb0365","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0370","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jcb.22294","article-title":"Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity","volume":"108","author":"Igwe","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0375","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0008-8749(02)00010-2","article-title":"Soluble CD26\/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate\/insulin-like growth factor II receptor","volume":"215","author":"Ikushima","year":"2002","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bone.2016.08.009_bb0380","article-title":"Review article: a comparison of glucagon-like peptides 1 and 2","author":"Janssen","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bone.2016.08.009_bb0385","first-page":"123","article-title":"Bone and brain: a review of neural, hormonal, and musculoskeletal connections","volume":"24","author":"Jones","year":"2004","journal-title":"Iowa Orthop. J."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0390","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bcp.2008.09.032","article-title":"In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma","volume":"77","author":"Jost","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12031-014-0389-1","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line","volume":"54","author":"Juhasz","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0400","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2013.04.009","article-title":"Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1","volume":"17","author":"Kajimura","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0405","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2006.10.008","article-title":"Convergence between bone and energy homeostases: leptin regulation of bone mass","volume":"4","author":"Karsenty","year":"2006","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0410","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11914-013-0157-0","article-title":"Influence of hormonal appetite and energy regulators on bone","volume":"11","author":"Khor","year":"2013","journal-title":"Current Osteoporosis Reports"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0415","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2009.10.015","article-title":"Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression","volume":"390","author":"Kim Chung le","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bone.2016.08.009_bb0420","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.lfs.2013.01.001","article-title":"Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/sclerostin in osteocytes","volume":"92","author":"Kim","year":"2013","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0425","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cellbi.2008.12.007","article-title":"Effects of substance P on osteoblastic differentiation and heme oxygenase-1 in human periodontal ligament cells","volume":"33","author":"Kook","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bone.2016.08.009_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2011.01.004","article-title":"Micellar nanomedicine of human neuropeptide Y","author":"Kuzmis","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bone.2016.08.009_bb0435","series-title":"Differential Effects of PPAR-g Activation vs. Chemical or Genetic Reduction of DPP-4 Activity on Murine Bone Quality","first-page":"196","author":"Kyle","year":"2010"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0440","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/en.2010-1098","article-title":"Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice","volume":"152","author":"Kyle","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0445","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejim.2013.01.009","article-title":"Incretin-based therapies in the treatment of type 2 diabetes - more than meets the eye?","volume":"24","author":"Labuzek","year":"2013","journal-title":"Eur. J. Intern. Med."},{"issue":"32","key":"10.1016\/j.bone.2016.08.009_bb0450","doi-asserted-by":"crossref","first-page":"29839","DOI":"10.1074\/jbc.M103106200","article-title":"Kinetic investigation of chemokine truncation by CD26\/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family","volume":"276","author":"Lambeir","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bone.2016.08.009_bb0460","doi-asserted-by":"crossref","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0465","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.npep.2009.08.006","article-title":"NPY regulation of bone remodelling","volume":"43","author":"Lee","year":"2009","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0470","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2010.10.174","article-title":"Osteoblast specific Y1 receptor deletion enhances bone mass","volume":"48","author":"Lee","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0475","first-page":"154","article-title":"Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide","volume":"8","author":"Lerner","year":"2008","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0480","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/jor.22440","article-title":"CXCR4 antagonism attenuates load-induced periosteal bone formation in mice","volume":"31","author":"Leucht","year":"2013","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0485","doi-asserted-by":"crossref","first-page":"301","DOI":"10.59566\/IJBS.2010.6301","article-title":"Downregulation of signaling-active IGF-1 by dipeptidyl peptidase IV (DPP-IV)","volume":"6","author":"Lin","year":"2010","journal-title":"Int. J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0490","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jcp.20435","article-title":"CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients","volume":"206","author":"Lisignoli","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"7 Suppl","key":"10.1016\/j.bone.2016.08.009_bb0495","first-page":"22","article-title":"Role of IGF-I on PTH effects on bone","volume":"33","author":"Lombardi","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bone.2016.08.009_bb0500","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-010-9208-y","article-title":"Peptidomics of the prolyl peptidases","author":"Lone","year":"2010","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0505","doi-asserted-by":"crossref","first-page":"e0132744","DOI":"10.1371\/journal.pone.0132744","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide has anabolic bone effects in ovariectomized rats without diabetes","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0510","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10875-007-9093-z","article-title":"Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma","volume":"27","author":"Lun","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jemt.10124","article-title":"Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells","volume":"58","author":"Lundberg","year":"2002","journal-title":"Microsc. Res. Tech."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0520","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S8756-3282(00)00394-X","article-title":"Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts","volume":"27","author":"Lundberg","year":"2000","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0525","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.142.1.7912","article-title":"Vasoactive intestinal peptide (VIP)\/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors","volume":"142","author":"Lundberg","year":"2001","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0530","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0535","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.npep.2012.12.002","article-title":"Neuropeptides stimulate human osteoblast activity and promote gap junctional intercellular communication","volume":"47","author":"Ma","year":"2013","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/JOE-13-0146","article-title":"Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor","volume":"219","author":"Mabilleau","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2016.08.009_bb0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2014.02.013","article-title":"Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties","volume":"63","author":"Mabilleau","year":"2014","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0550","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12102","article-title":"Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials (-1meta)","volume":"6","author":"Mabilleau","year":"2014","journal-title":"J. Diabetes"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0555","first-page":"130","article-title":"Drugs for type 2 diabetes: role in the regulation of bone metabolism","volume":"12","author":"Mannucci","year":"2015","journal-title":"Clinical Cases in Mineral and Bone Metabolism"},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0560","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00125-005-1749-8","article-title":"Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus","volume":"48","author":"Mannucci","year":"2005","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0565","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/jcp.25033","article-title":"Stable incretin mimetics counter rapid deterioration of bone quality in type 1 diabetes mellitus","volume":"230","author":"Mansur","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0570","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1073\/pnas.120069197","article-title":"Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26","volume":"97","author":"Marguet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0575","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1210\/en.2006-1541","article-title":"Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway","volume":"148","author":"Martin","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.08.009_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2011.04.004","article-title":"Effects of estrous cycle and sex on the expression of neuropeptide Y Y1 receptor in discrete hypothalamic and limbic nuclei of transgenic mice","author":"Martini","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.bone.2016.08.009_bb0585","article-title":"DPPIV - serum activity and expression on lymphocytes in different hematological malignancies","author":"Matic","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bone.2016.08.009_bb0590","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0083-6729(08)00615-8","article-title":"Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP)","volume":"80","author":"McIntosh","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bone.2016.08.009_bb0595","article-title":"Effects of diabetes drugs on the skeleton","author":"Meier","year":"2015","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0600","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bone.2016.08.009_bb0605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2015.01.003","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures","volume":"74","author":"Mieczkowska","year":"2015","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0610","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2005-1878","article-title":"Elevated peptide YY levels in adolescent girls with anorexia nervosa","volume":"91","author":"Misra","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0615","doi-asserted-by":"crossref","first-page":"e57375","DOI":"10.1371\/journal.pone.0057375","article-title":"Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice","volume":"8","author":"Mizokami","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0620","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0625","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1902\/jop.2015.150278","article-title":"Exenatide and sitagliptin decrease interleukin 1beta, matrix metalloproteinase 9, and nitric oxide synthase 2 gene expression but does not reduce alveolar bone loss in rats with periodontitis","volume":"86","author":"Moraes","year":"2015","journal-title":"J. Periodontol."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0630","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/000456327801500138","article-title":"Radioimmunoassay of gastric inhibitory polypeptide","volume":"15","author":"Morgan","year":"1978","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0635","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.2599","article-title":"The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK","volume":"271","author":"Mukohyama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0640","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn1454","article-title":"Molecular and anatomical determinants of central leptin resistance","volume":"8","author":"Munzberg","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0645","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bone.2008.07.241","article-title":"IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts","volume":"43","author":"Nakasaki","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2016.08.009_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2277","article-title":"Blockade of CD26 signaling inhibits human osteoclast development","author":"Nishida","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0655","doi-asserted-by":"crossref","first-page":"E2325","DOI":"10.1210\/jc.2014-2547","article-title":"Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans","volume":"99","author":"Nissen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0660","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0665","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.22243","article-title":"Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor","volume":"225","author":"Nuche-Berenguer","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0670","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JOE-11-0015","article-title":"GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia","volume":"209","author":"Nuche-Berenguer","year":"2011","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0675","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1742-4658.2009.07482.x","article-title":"Neuropeptide Y expression and function during osteoblast differentiation\u2014insights from transthyretin knockout mice","volume":"277","author":"Nunes","year":"2010","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0680","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0685","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0690","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1634\/stemcells.2007-0515","article-title":"Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4\/stromal cell-derived factor-1 pathway","volume":"26","author":"Otsuru","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0695","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2013-02-487470","article-title":"Implications of DPP4 modification of proteins that regulate stem\/progenitor and more mature cell types","volume":"122","author":"Ou","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bone.2016.08.009_bb0700","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0705","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6793-11-12","article-title":"Receptors and effects of gut hormones in three osteoblastic cell lines","volume":"11","author":"Pacheco-Pantoja","year":"2011","journal-title":"BMC Physiol."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0710","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bone.2009.04.204","article-title":"Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents","volume":"45","author":"Pacifico","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2016.08.009_bb0715","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4615-9543-4_45","article-title":"Dipeptidyl(amino)peptidase IV and post proline cleaving enzyme in cultured endothelial and smooth muscle cells","volume":"247A","author":"Palmieri","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bone.2016.08.009_bb0720","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","article-title":"Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice","volume":"81","author":"Pereira","year":"2015","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0725","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/bbrc.2000.3151","article-title":"Microisolated mouse osteoclasts express VIP-1 and PACAP receptors","volume":"274","author":"Ransjo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00223-002-0015-z","article-title":"Direct actions of leptin on bone remodeling","volume":"74","author":"Reid","year":"2004","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0735","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bone.2003.07.008","article-title":"Serum leptin as a determinant of bone resorption in healthy postmenopausal women","volume":"33","author":"Roux","year":"2003","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0740","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1515\/BC.2004.063","article-title":"Evidence for an interaction between leptin, T cell costimulatory antigens CD28, CTLA-4 and CD26 (dipeptidyl peptidase IV) in BCG-induced immune responses of leptin- and leptin receptor-deficient mice","volume":"385","author":"Ruter","year":"2004","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0745","first-page":"613","article-title":"Effect of sitagliptin on the working memory and reference memory in type 2 diabetic Sprague-Dawley rats: possible role of adiponectin receptors 1","volume":"64","author":"Sakr","year":"2013","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bone.2016.08.009_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2014.01.028","article-title":"Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells","author":"Sbaraglini","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bone.2016.08.009_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2011.04.011","article-title":"Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women","author":"Scheid","year":"2011","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2016.08.009_bb0760","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-128-10-199805150-00002","article-title":"Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Schurch","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2016.08.009_bb0765","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4172\/2155-6156.1000157","article-title":"Sitagliptin suppresses active ghrelin in patients with diabetes","volume":"2","author":"Seyoum","year":"2011","journal-title":"Journal of Diabetes & Metabolism"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0770","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bone.2011.10.001","article-title":"Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue","volume":"50","author":"Shi","year":"2012","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.bone.2016.08.009_bb0775","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clinbiochem.2012.04.023","article-title":"Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD","volume":"45","author":"Somborac-Bacura","year":"2012","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0780","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138945009787122888","article-title":"NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target","volume":"10","author":"Sousa","year":"2009","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0785","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1359\/JBMR.051004","article-title":"Immunocompetent properties of human osteoblasts: interactions with T lymphocytes","volume":"21","author":"Stanley","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0790","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/8756-3282(96)00079-8","article-title":"Hyperinsulinemia and bone mineral density in an elderly population: the Rotterdam Study","volume":"18","author":"Stolk","year":"1996","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.bone.2016.08.009_bb0795","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1128\/MCB.23.22.7973-7981.2003","article-title":"Deletion of ghrelin impairs neither growth nor appetite","volume":"23","author":"Sun","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0800","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/1753-0407.12282","article-title":"Liraglutide, the glucagon-like peptide-1 receptor agonist, has anabolic bone effects in diabetic Goto-Kakizaki rats","volume":"7","author":"Sun","year":"2015","journal-title":"J. Diabetes"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0805","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jcb.22194","article-title":"NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors","volume":"107","author":"Teixeira","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0810","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0007114513002341","article-title":"Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human study","volume":"111","author":"Trautvetter","year":"2014","journal-title":"The British Journal of Nutrition"},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0815","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1210\/me.2005-0187","article-title":"Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion","volume":"20","author":"Tsukiyama","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2016.08.009_bb0820","article-title":"Feeding and bone turnover in gastric bypass","author":"Valderas","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bone.2016.08.009_bb0825","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1210\/en.2012-1277","article-title":"An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects","volume":"153","author":"van der Velde","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0830","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1359\/jbmr.090827","article-title":"Hyponatremia-induced osteoporosis","volume":"25","author":"Verbalis","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0835","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.abb.2010.06.020","article-title":"Feeding and bone","volume":"503","author":"Walsh","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2016.08.009_bb0840","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/bonekey.2014.83","article-title":"The hunger games of skeletal metabolism","volume":"3","author":"Wee","year":"2014","journal-title":"BoneKEy Reports"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0845","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0850","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1113\/expphysiol.1997.sp004070","article-title":"Pituitary adenylyl cyclase-activating polypeptides and vasoactive intestinal peptide inhibit bone resorption by isolated rabbit osteoclasts","volume":"82","author":"Winding","year":"1997","journal-title":"Exp. Physiol."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0855","doi-asserted-by":"crossref","first-page":"e40038","DOI":"10.1371\/journal.pone.0040038","article-title":"Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0860","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2007.08.024","article-title":"Peptide YY regulates bone turnover in rodents","volume":"133","author":"Wortley","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bone.2016.08.009_bb0865","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bone.2005.01.021","article-title":"Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts","volume":"36","author":"Wright","year":"2005","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2016.08.009_bb0870","doi-asserted-by":"crossref","first-page":"E1418","DOI":"10.1152\/ajpendo.00048.2014","article-title":"Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice","volume":"306","author":"Wu","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2016.08.009_bb0875","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0880","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bone.2005.06.021","article-title":"Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover","volume":"37","author":"Xie","year":"2005","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0885","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0022034510379019","article-title":"LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4","volume":"90","author":"Xing","year":"2011","journal-title":"J. Dent. Res."},{"issue":"6","key":"10.1016\/j.bone.2016.08.009_bb0890","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2337\/db06-1033","article-title":"Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0895","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada","year":"2008","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2016.08.009_bb0900","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5312\/wjo.v1.i1.3","article-title":"Bone fragility in type 2 diabetes mellitus","volume":"1","author":"Yamaguchi","year":"2010","journal-title":"World Journal of Orthopedics"},{"issue":"4","key":"10.1016\/j.bone.2016.08.009_bb0905","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.lfs.2007.04.040","article-title":"Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin","volume":"81","author":"Yang","year":"2007","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bone.2016.08.009_bb0910","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ijo.2012.71","article-title":"Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice","volume":"37","author":"Zengin","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bone.2016.08.009_bb0915","article-title":"Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK","author":"Zhang","year":"2012","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bone.2016.08.009_bb0920","doi-asserted-by":"crossref","DOI":"10.2174\/138161212803216988","article-title":"The role of NPY and Ghrelin in anorexia nervosa","author":"Zhang","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.bone.2016.08.009_bb0925","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1210\/jc.2015-2233","article-title":"Plasma DPP4 activities are associated with osteoporosis in postmenopausal women with normal glucose tolerance","volume":"100","author":"Zheng","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0930","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.1152\/ajpendo.00364.2006","article-title":"Effects of glucose-dependent insulinotropic peptide on osteoclast function","volume":"292","author":"Zhong","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2016.08.009_bb0935","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.83.2.187","article-title":"Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium","volume":"83","author":"Zukowska-Grojec","year":"1998","journal-title":"Circ. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T21:25:35Z","timestamp":1718745935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216302289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":187,"alternative-id":["S8756328216302289"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.08.009","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}